A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism
| Autor: | Yoshihiko Takahashi, Yuji Taketani, Hiroko Kadowaki, Takashi Kadowaki, Yasuo Akanuma, T. Okai, Tihamer Orban, Yoshio Yazaki, Yasushi Fukushima, K Momomura |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Adult
Male medicine.medical_specialty Endocrinology Diabetes and Metabolism medicine.medical_treatment CHO Cells Transfection Polymerase Chain Reaction Insulin resistance Pregnancy Internal medicine Cricetinae Internal Medicine medicine Missense mutation Animals Humans Insulin Lymphocytes Insulin-Like Growth Factor I Receptor Glycogen synthase Cells Cultured Growth Disorders Skin biology Infant DNA Syndrome Fibroblasts medicine.disease Receptor Insulin Recombinant Proteins Insulin receptor Endocrinology Glycogen Synthase biology.protein Amniocentesis Mutagenesis Site-Directed Female Donohue syndrome Tyrosine kinase |
| Zdroj: | Diabetologia. 40(4) |
| ISSN: | 0012-186X |
| Popis: | We report a homozygous missense mutation at position 1092 (substitution of glutamine for arginine) in the tyrosine kinase domain of the insulin receptor in a patient with leprechaunism associated with severe insulin resistance and intrauterine growth retardation. Site-directed mutagenesis as well as analyses of the patient's lymphocytes revealed that this mutation causes a marked decrease in tyrosine kinase activity of the insulin receptor without any defect in insulin binding, which causes severe defects in insulin-stimulated glucose transport, glycogen synthesis and DNA synthesis. Thus, this is the first homozygous mutation resulting in a selective-kinase defect of the insulin receptor. Interestingly, the parents who are cousins and are heterozygous for the mutation have type A insulin resistance syndrome. This correlation between genotype and phenotype in a single pedigree suggests that the severity of the mutation will determine the phenotype. Based upon this assumption, we have been successful in prenatal diagnosis of the fifth child. Furthermore, we have demonstrated the effectiveness of clinical administration of insulin-like growth factor-I (IGF-I) in this patient and in vitro analysis of the patient's skin fibroblasts, suggesting that IGF-I can compensate for insulin action via the IGF-I receptor in a patient almost lacking functional insulin receptors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink